Low albumin concentration in patients with metastatic breast cancer was positively correlated with the probability of lower cancer-specific survival due to the presence of systemic inflammation and the patient’s frailty, both factors that can influence the progression of the disease and the response to treatment [110]. This evidence concerns the gene ALB and cancer.